Ïã¸Û6ºÏ¿ª½±½á¹û

Chair
Venture Valkyrie

Tvardi Therapeutics, Inc.

SFA Consulting, LLC

NASA astronaut (retired), Global Explorer in Residence at Arizona State University and Research Affiliate at the MIT Media Lab

DNAnexus, Inc. 

 
Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences

Stanford University

BAJ Accelerator

First Spark Ventures

University of California San Francisco

University of Louisville School of Medicine

Texas Tech University

NASA astronaut (retired), Founding Director, Space for Art Foundation

Takeda Pharmaceuticals

Regeneron Pharmaceuticals

In March of 2021, TRISH added seven outstanding thought leaders, including two female astronauts, to its Scientific Advisory Board that provides strategic guidance to the Institute.  

TRISH leads a national effort in translating terrestrial research that can help guard human health in space exploration. As NASA prepares to go back to the Moon via Artemis missions and SpaceX prepares to launch the first all-civilian crew to space in late 2021, our mission to keep all space travelers healthy is more vital than ever.

"We are at the cusp of space becoming more accessible to regular people. We are working toward safeguarding the health of all humans - - astronauts exploring deep space and people with pre-existing conditions that want to experience space for short periods. TRISH's diverse advisory board members will help us focus our resources on the most impactful health technology and science innovations," said Institute Director Dorit Donoviel, Ph.D.

"From pharma and industry leaders to retired astronauts, this board benefits from an incredible wealth of technical and practical experience and leadership," said Scientific Advisory Board Chair Lisa Suennen. "This is the right group to expand TRISH's reach and help us push on the boundaries of what we think we know about protecting the body and mind in space."